Cover Image
Market Research Report
Product code 
1035645

Clinical Trial Supplies Market Research Report by Services, by Type, by Phase, by Therapeutic Area, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

Published: | 360iResearch LLP | 180 Pages | Delivery time: 1-2 business days

Price

Back to Top
Clinical Trial Supplies Market Research Report by Services, by Type, by Phase, by Therapeutic Area, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
Published: November 4, 2021
360iResearch LLP
Content info: 180 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The Global Clinical Trial Supplies Market size was estimated at USD 1,902.84 million in 2020 and expected to reach USD 2,026.52 million in 2021, at a CAGR 6.83% to reach USD 2,829.87 million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Clinical Trial Supplies to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Services, the market was studied across Comparator Sourcing, Logistics & Distribution, Manufacturing, Packaging, Labeling, & Blinding, and Storage & Retention. The Logistics & Distribution is further studied across Cold Chain Distribution and Non-Cold Chain Distribution.
  • Based on Type, the market was studied across Biologic Drugs, Medical Devices, and Small Molecules.
  • Based on Phase, the market was studied across BA/ BE studies, Phase 1, Phase 2, Phase 3, and Phase 4.
  • Based on Therapeutic Area, the market was studied across Blood Disorders, Cardiovascular Diseases, CNS & Mental Disorders, Dermatological Disorders, Digestive Disorders, ENT Diseases, Immunology, Infectious Diseases, Metabolic Disorders, Nephrology, Oncology, Rare Diseases, and Respiratory Disorders.
  • Based on End User, the market was studied across Contract Research Organisations (CROs), Medical Devices Companies, and Pharmaceutical & Biotechnology companies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Trial Supplies Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Clinical Trial Supplies Market, including Almac Group, Ancillare, LP, Biocair, Catalent, Inc., Clinigen Group, Eurofins Scientific, Inc., Infosys Limited, KLIFO A/S, Liveo Research GmbH, Marken, Myonex, Inc., N-SIDE, Parexel International, PCI Pharma Services, Piramal Pharma Solutions, PRA Health Sciences, SIRO Clinpharm Pvt. Ltd., The Piramal Group, Thermo Fisher Scientific, and UDG Healthcare plc.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Clinical Trial Supplies Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Clinical Trial Supplies Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Clinical Trial Supplies Market?
  • 4. What is the competitive strategic window for opportunities in the Global Clinical Trial Supplies Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Clinical Trial Supplies Market?
  • 6. What is the market share of the leading vendors in the Global Clinical Trial Supplies Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Clinical Trial Supplies Market?
Table of Contents
Product Code: MRR-501246436332

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Define: Research Objective
  • 2.3. Determine: Research Design
  • 2.4. Prepare: Research Instrument
  • 2.5. Collect: Data Source
  • 2.6. Analyze: Data Interpretation
  • 2.7. Formulate: Data Verification
  • 2.8. Publish: Research Report
  • 2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Incidence of Chronic Diseases
      • 5.1.1.2. Government Funds to R&D Investments
      • 5.1.1.3. Development of New Treatment Such as Personalized Medicine
    • 5.1.2. Restraints
      • 5.1.2.1. High Cost Associated With the Clinical Trials
    • 5.1.3. Opportunities
      • 5.1.3.1. New Drug Development and Availability in Emerging Countries
      • 5.1.3.2. Increasing Demand for Innovative Solutions in Clinical Trials Services
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of Skilled Person to Operate Devices During Clinical Trials
  • 5.2. Cumulative Impact of COVID-19

6. Clinical Trial Supplies Market, by Services

  • 6.1. Introduction
  • 6.2. Comparator Sourcing
  • 6.3. Logistics & Distribution
    • 6.3.1. Cold Chain Distribution
    • 6.3.2. Non-Cold Chain Distribution
  • 6.4. Manufacturing
  • 6.5. Packaging, Labeling, & Blinding
  • 6.6. Storage & Retention

7. Clinical Trial Supplies Market, by Type

  • 7.1. Introduction
  • 7.2. Biologic Drugs
  • 7.3. Medical Devices
  • 7.4. Small Molecules

8. Clinical Trial Supplies Market, by Phase

  • 8.1. Introduction
  • 8.2. BA/ BE studies
  • 8.3. Phase 1
  • 8.4. Phase 2
  • 8.5. Phase 3
  • 8.6. Phase 4

9. Clinical Trial Supplies Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Blood Disorders
  • 9.3. Cardiovascular Diseases
  • 9.4. CNS & Mental Disorders
  • 9.5. Dermatological Disorders
  • 9.6. Digestive Disorders
  • 9.7. ENT Diseases
  • 9.8. Immunology
  • 9.9. Infectious Diseases
  • 9.10. Metabolic Disorders
  • 9.11. Nephrology
  • 9.12. Oncology
  • 9.13. Rare Diseases
  • 9.14. Respiratory Disorders

10. Clinical Trial Supplies Market, by End User

  • 10.1. Introduction
  • 10.2. Contract Research Organisations (CROs)
  • 10.3. Medical Devices Companies
  • 10.4. Pharmaceutical & Biotechnology companies

11. Americas Clinical Trial Supplies Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Clinical Trial Supplies Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand

13. Europe, Middle East & Africa Clinical Trial Supplies Market

  • 13.1. Introduction
  • 13.2. France
  • 13.3. Germany
  • 13.4. Italy
  • 13.5. Netherlands
  • 13.6. Qatar
  • 13.7. Russia
  • 13.8. Saudi Arabia
  • 13.9. South Africa
  • 13.10. Spain
  • 13.11. United Arab Emirates
  • 13.12. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
    • 14.1.1. Quadrants
    • 14.1.2. Business Strategy
    • 14.1.3. Product Satisfaction
  • 14.2. Market Ranking Analysis
  • 14.3. Market Share Analysis, By Key Player
  • 14.4. Competitive Scenario
    • 14.4.1. Merger & Acquisition
    • 14.4.2. Agreement, Collaboration, & Partnership
    • 14.4.3. New Product Launch & Enhancement
    • 14.4.4. Investment & Funding
    • 14.4.5. Award, Recognition, & Expansion

15. Company Usability Profiles

  • 15.1. Almac Group
  • 15.2. Ancillare, LP
  • 15.3. Biocair
  • 15.4. Catalent, Inc.
  • 15.5. Clinigen Group
  • 15.6. Eurofins Scientific, Inc.
  • 15.7. Infosys Limited
  • 15.8. KLIFO A/S
  • 15.9. Liveo Research GmbH
  • 15.10. Marken
  • 15.11. Myonex, Inc.
  • 15.12. N-SIDE
  • 15.13. Parexel International
  • 15.14. PCI Pharma Services
  • 15.15. Piramal Pharma Solutions
  • 15.16. PRA Health Sciences
  • 15.17. SIRO Clinpharm Pvt. Ltd.
  • 15.18. The Piramal Group
  • 15.19. Thermo Fisher Scientific
  • 15.20. UDG Healthcare plc

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. GLOBAL CLINICAL TRIAL SUPPLIES MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL CLINICAL TRIAL SUPPLIES MARKET: MARKET DYNAMICS
  • FIGURE 3. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SERVICES, 2020 VS 2026 (%)
  • FIGURE 4. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SERVICES, 2020 VS 2026 (USD MILLION)
  • FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SERVICES, 2026
  • FIGURE 6. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COMPARATOR SOURCING, 2018-2026 (USD MILLION)
  • FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COMPARATOR SOURCING, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2026 (USD MILLION)
  • FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LOGISTICS & DISTRIBUTION, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COLD CHAIN DISTRIBUTION, 2018-2026 (USD MILLION)
  • FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COLD CHAIN DISTRIBUTION, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY NON-COLD CHAIN DISTRIBUTION, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY NON-COLD CHAIN DISTRIBUTION, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MANUFACTURING, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MANUFACTURING, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING, LABELING, & BLINDING, 2018-2026 (USD MILLION)
  • FIGURE 17. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING, LABELING, & BLINDING, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STORAGE & RETENTION, 2018-2026 (USD MILLION)
  • FIGURE 19. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STORAGE & RETENTION, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
  • FIGURE 21. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2026
  • FIGURE 23. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOLOGIC DRUGS, 2018-2026 (USD MILLION)
  • FIGURE 24. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 25. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SMALL MOLECULES, 2018-2026 (USD MILLION)
  • FIGURE 28. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2020 VS 2026 (%)
  • FIGURE 30. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2020 VS 2026 (USD MILLION)
  • FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2026
  • FIGURE 32. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BA/ BE STUDIES, 2018-2026 (USD MILLION)
  • FIGURE 33. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BA/ BE STUDIES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 34. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE 1, 2018-2026 (USD MILLION)
  • FIGURE 35. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE 1, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 36. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE 2, 2018-2026 (USD MILLION)
  • FIGURE 37. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE 2, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 38. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE 3, 2018-2026 (USD MILLION)
  • FIGURE 39. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE 3, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 40. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE 4, 2018-2026 (USD MILLION)
  • FIGURE 41. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE 4, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 42. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2020 VS 2026 (%)
  • FIGURE 43. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2020 VS 2026 (USD MILLION)
  • FIGURE 44. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2026
  • FIGURE 45. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BLOOD DISORDERS, 2018-2026 (USD MILLION)
  • FIGURE 46. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 47. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2026 (USD MILLION)
  • FIGURE 48. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 49. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CNS & MENTAL DISORDERS, 2018-2026 (USD MILLION)
  • FIGURE 50. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CNS & MENTAL DISORDERS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 51. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DERMATOLOGICAL DISORDERS, 2018-2026 (USD MILLION)
  • FIGURE 52. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 53. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DIGESTIVE DISORDERS, 2018-2026 (USD MILLION)
  • FIGURE 54. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 55. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ENT DISEASES, 2018-2026 (USD MILLION)
  • FIGURE 56. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ENT DISEASES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 57. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IMMUNOLOGY, 2018-2026 (USD MILLION)
  • FIGURE 58. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 59. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2026 (USD MILLION)
  • FIGURE 60. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 61. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY METABOLIC DISORDERS, 2018-2026 (USD MILLION)
  • FIGURE 62. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 63. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY NEPHROLOGY, 2018-2026 (USD MILLION)
  • FIGURE 64. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY NEPHROLOGY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 65. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ONCOLOGY, 2018-2026 (USD MILLION)
  • FIGURE 66. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 67. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY RARE DISEASES, 2018-2026 (USD MILLION)
  • FIGURE 68. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY RARE DISEASES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 69. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY RESPIRATORY DISORDERS, 2018-2026 (USD MILLION)
  • FIGURE 70. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 71. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2020 VS 2026 (%)
  • FIGURE 72. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 73. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2026
  • FIGURE 74. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS (CROS), 2018-2026 (USD MILLION)
  • FIGURE 75. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS (CROS), BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 76. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES COMPANIES, 2018-2026 (USD MILLION)
  • FIGURE 77. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES COMPANIES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 78. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2026 (USD MILLION)
  • FIGURE 79. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 80. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 81. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 82. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 83. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 84. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 85. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 86. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 87. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 88. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 89. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 90. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 91. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 92. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 93. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 94. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 95. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 96. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 97. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 98. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 99. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 100. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 101. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 102. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 103. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 104. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 105. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 106. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 107. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 108. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 109. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 110. GLOBAL CLINICAL TRIAL SUPPLIES MARKET: FPNV POSITIONING MATRIX
  • FIGURE 111. GLOBAL CLINICAL TRIAL SUPPLIES MARKET: SHARE, BY KEY PLAYER, 2020
  • FIGURE 112. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CLINICAL TRIAL SUPPLIES MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL CLINICAL TRIAL SUPPLIES MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SERVICES, 2018-2026 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COMPARATOR SOURCING, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LOGISTICS & DISTRIBUTION, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 6. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COLD CHAIN DISTRIBUTION, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 7. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY NON-COLD CHAIN DISTRIBUTION, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PACKAGING, LABELING, & BLINDING, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STORAGE & RETENTION, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2026 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BA/ BE STUDIES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE 1, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE 2, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE 3, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE 4, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2026 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CNS & MENTAL DISORDERS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ENT DISEASES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 31. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 32. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 33. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 34. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 35. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
  • TABLE 36. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS (CROS), BY REGION, 2018-2026 (USD MILLION)
  • TABLE 37. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES COMPANIES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 38. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 39. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 40. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 41. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 42. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 43. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 44. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 46. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 47. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 48. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 49. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 50. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 51. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 52. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 53. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 54. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 55. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 56. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 58. FRANCE CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 59. GERMANY CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 60. ITALY CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 61. NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 62. QATAR CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 63. RUSSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 64. SAUDI ARABIA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 65. SOUTH AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 66. SPAIN CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 67. UNITED ARAB EMIRATES CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 68. UNITED KINGDOM CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 69. GLOBAL CLINICAL TRIAL SUPPLIES MARKET: SCORES
  • TABLE 70. GLOBAL CLINICAL TRIAL SUPPLIES MARKET: BUSINESS STRATEGY
  • TABLE 71. GLOBAL CLINICAL TRIAL SUPPLIES MARKET: PRODUCT SATISFACTION
  • TABLE 72. GLOBAL CLINICAL TRIAL SUPPLIES MARKET: RANKING
  • TABLE 73. GLOBAL CLINICAL TRIAL SUPPLIES MARKET: SHARE, BY KEY PLAYER, 2020
  • TABLE 74. GLOBAL CLINICAL TRIAL SUPPLIES MARKET: MERGER & ACQUISITION
  • TABLE 75. GLOBAL CLINICAL TRIAL SUPPLIES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 76. GLOBAL CLINICAL TRIAL SUPPLIES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 77. GLOBAL CLINICAL TRIAL SUPPLIES MARKET: INVESTMENT & FUNDING
  • TABLE 78. GLOBAL CLINICAL TRIAL SUPPLIES MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 79. GLOBAL CLINICAL TRIAL SUPPLIES MARKET: LICENSE & PRICING